Literature DB >> 17242882

[Primary open angle glaucoma. Morphological bases for the understanding of the pathogenesis and effects of antiglaucomatic substances].

E Lütjen-Drecoll1, F E Kruse.   

Abstract

The pathogenesis of glaucomatic illnesses is poorly understood. An increase in ocular pressure can be caused by an increase in the secretion of aqueous humour or a reduction in its outflow. In the elderly, outflow is reduced while at the same time less aqueous humour is produced. This balance is easily disturbed, so that age represents a risk factor for glaucoma in addition to increased ocular pressure. Therapeutic possibilities involve, on the one hand, reducing the secretion of aqueous humour, for example using, beta blockers, carbonic anhydrase inhibitors and clonidine. On the other hand, aqueous humour outflow can also be influenced by drugs. Conventional outflow is increased by the administration of miotics. The uveoscleral outflow can be increased by prostaglandin derivates. Drugs which only influence trabecular outflow are not yet available. Future therapeutic possibilities involve new aspects of the pathophysiology, e.c. the use of growth factors, free radical scavenging enzymes and choroidal blood flow.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17242882     DOI: 10.1007/s00347-007-1481-5

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  13 in total

1.  Morphological changes in primate aqueous humor formation and drainage tissues after long-term treatment with antiglaucomatous drugs.

Authors:  E Lütjen-Drecoll; P L Kaufman
Journal:  J Glaucoma       Date:  1993       Impact factor: 2.503

2.  Pathophysiologic changes in the optic nerves of eyes with primary open angle and pseudoexfoliation glaucoma.

Authors:  Johannes Gottanka; Alexander Kuhlmann; Michael Scholz; Douglas H Johnson; Elke Lütjen-Drecoll
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-11       Impact factor: 4.799

3.  Efferent and afferent innervation of primate trabecular meshwork and scleral spur.

Authors:  J M Selbach; J Gottanka; M Wittmann; E Lütjen-Drecoll
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-07       Impact factor: 4.799

4.  Induction of tissue transglutaminase in the trabecular meshwork by TGF-beta1 and TGF-beta2.

Authors:  U Welge-Lüssen; C A May; E Lütjen-Drecoll
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-07       Impact factor: 4.799

5.  Transforming growth factor-beta 2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes.

Authors:  Rudolf Fuchshofer; Marco Birke; Ulrich Welge-Lussen; Daniel Kook; Elke Lütjen-Drecoll
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-02       Impact factor: 4.799

6.  Angioarchitecture and innervation of the primate anterior episclera.

Authors:  J Michael Selbach; Johannes W Rohen; Klaus-Peter Steuhl; Elke Lütjen-Drecoll
Journal:  Curr Eye Res       Date:  2005-05       Impact factor: 2.424

7.  Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide.

Authors:  Markus Richter; Achim H-P Krauss; David F Woodward; Elke Lütjen-Drecoll
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-10       Impact factor: 4.799

8.  Carbonic anhydrase distribution in the human and monkey eye by light and electron microscopy.

Authors:  E Lütjen-Drecoll; G Lönnerholm; M Eichhorn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

9.  Age changes in rhesus monkey ciliary muscle: light and electron microscopy.

Authors:  E Lütjen-Drecoll; E Tamm; P L Kaufman
Journal:  Exp Eye Res       Date:  1988-12       Impact factor: 3.467

10.  Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide.

Authors:  M Wiederholt; A Sturm; A Lepple-Wienhues
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-04       Impact factor: 4.799

View more
  7 in total

1.  A modified scleral dissection technique with suprachoroidal drainage for canaloplasty.

Authors:  Peter Szurman; Kai Januschowski; Karl Thomas Boden; Gesine Bettina Szurman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-14       Impact factor: 3.117

2.  Modified canaloplasty with suprachoroidal drainage versus conventional canaloplasty-1-year results.

Authors:  Anna-Maria Seuthe; Ciprian Ivanescu; Stephan Leers; Karl Boden; Kai Januschowski; Peter Szurman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-05-10       Impact factor: 3.117

3.  High myopia as a risk factor in primary open angle glaucoma.

Authors:  Sheng-Ju Chen; Peng Lu; Wen-Fang Zhang; Jian-Hua Lu
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

Review 4.  [Modifications of canaloplasty : Strong pressure-lowering effect with a low risk profile].

Authors:  Peter Szurman; Karsten Klabe
Journal:  Ophthalmologie       Date:  2022-05-31

5.  Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucoma.

Authors:  Francesca Pasutto; Tomoya Matsumoto; Christian Y Mardin; Heinrich Sticht; Johann H Brandstätter; Karin Michels-Rautenstrauss; Nicole Weisschuh; Eugen Gramer; Wishal D Ramdas; Leonieke M E van Koolwijk; Caroline C W Klaver; Johannes R Vingerling; Bernhard H F Weber; Friedrich E Kruse; Bernd Rautenstrauss; Yves-Alain Barde; André Reis
Journal:  Am J Hum Genet       Date:  2009-09-17       Impact factor: 11.025

6.  Genetic association and stress mediated down-regulation in trabecular meshwork implicates MPP7 as a novel candidate gene in primary open angle glaucoma.

Authors:  Mansi Vishal; Anchal Sharma; Lalit Kaurani; Giovanna Alfano; Suddhasil Mookherjee; Kiran Narta; Jyoti Agrawal; Iman Bhattacharya; Susanta Roychoudhury; Jharna Ray; Naushin H Waseem; Shomi S Bhattacharya; Analabha Basu; Abhijit Sen; Kunal Ray; Arijit Mukhopadhyay
Journal:  BMC Med Genomics       Date:  2016-03-22       Impact factor: 3.063

7.  Can neuroprotection effectively manage primary open-angle glaucoma? a protocol of systematic review and meta-analysis.

Authors:  Yan-Xiu Qi; Jian Zhang; Xing-Jie Su
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.